American Regent® Launches Gvoke VialDx™ (glucagon injection)
Provided By PR Newswire
Last update: Aug 27, 2025
First concentrated, ready-to-dilute liquid glucagon available for diagnostic procedures
SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc.® is pleased to announce the commercial launch and availability of Gvoke VialDx™ (glucagon injection).
Read more at prnewswire.com
